Edition:
United States

People: Henry Schein Inc (HSIC.OQ)

HSIC.OQ on NASDAQ Stock Exchange Global Select Market

68.89USD
21 May 2019
Change (% chg)

$0.40 (+0.58%)
Prev Close
$68.49
Open
$68.82
Day's High
$69.35
Day's Low
$68.75
Volume
515,109
Avg. Vol
630,486
52-wk High
$91.35
52-wk Low
$56.58

Brons, Paul 

Mr. Paul Brons serves as Independent Director of the Company. Between 1994 and 2002, Mr. Brons served as an executive board member of Akzo Nobel, N.V. From 1965 to 1994, Mr. Brons held various positions with Organon International BV, including President from 1983 to 1994 and Deputy President from 1979 to 1983. From 1975 to 1979, Mr. Brons served as the General Manager of the OTC operations of Chefaro, and from 1965 to 1975 in marketing and general management functions for Organon in various Middle East and Latin American countries. Both Organon and Chefaro operated within the Akzo Nobel group. Mr. Brons brings to the Company’s Board of Directors knowledge of the human and animal health pharmaceutical industry (a part of our medical and animal health businesses) and experience with international business operations and relations. The Board of Directors is also aided by Mr. Brons’ knowledge of European business culture and his strategic focus on European health care issues. Mr. Brons was honored in 1996 by Her Majesty the Queen with the decoration of Knight of the Order of Lion of the Kingdom of the Netherlands, the country’s highest civilian order, conferred for his meritorious achievements for Akzo Nobel and other international activities.

Basic Compensation

Total Annual Compensation, USD 79,000
Restricted Stock Awards, USD 185,400
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 264,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --